Australian-made disinfectant given a COVID-19-killing approved label claim

disinfectant COVID-19

Following recent changes to the Guidelines for Disinfectants under Therapeutic Goods Order 104, which allow listed disinfectants to make validated claims to kill the SARS-CoV-2 (COVID-19) virus on surfaces, VIRACLEAN®—manufactured by the Whiteley Corporation—has the first newly approved label claim for killing the SARS-CoV-2 (COVID-19) virus on contaminated surfaces. 

Viraclean® is a hospital-grade disinfectant intended for use on a wide range of surfaces which may be contaminated, better protecting patients and staff from the risk of SARS-CoV-2 (COVID-19) virus cross infection. (It is important to note that the product is a surface disinfectant and not intended for use directly on people, or for treating a patient.) 

Given the capacity of COVID-19 to survive on hard and relatively soft surfaces for a prolonged period of time, cleaning and disinfecting those surfaces is incredibly important to limiting the spread of the virus. 

“This new label claim for Viraclean® against the virus responsible for the current pandemic will add to certainty around the level of hygiene in hospitals, particularly in intensive care units, emergency departments, and a range of other clinical, medical and dental applications,” Whiteley Corporation chairman Dr Greg Whiteley said.

“These claims will also be applied to INSTRUMAX® PINK, which is used for disinfection of non-critical medical devices in the hospital and healthcare sector.” 

This article was sourced from the ADA website.

Previous articleDentists now have new item number for telehealth consultations
Next articleAmoeba linked to severe gum disease


Please enter your comment!
Please enter your name here